ATH 33.3% 0.4¢ alterity therapeutics limited

prominent ad researcher killed in accident, page-3

  1. 116 Posts.
    Great quote from the late Prof Smith, Skint:

    "He acknowledges that Wyeth and Elan may be able to document a small but statistically significant improvement in their final-stage trials, but he says it won't be clinically meaningful."

    Takes me back to out discussions on the importance of PBT's outcomes from 2008.....

    Merry Xmas,

    Alis
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.